FDA Approves First Oral Treatment for Canine Lymphoma
Cancer. It’s the word we all dread to hear. For dogs diagnosed with lymphosarcoma (malignant lymphoma), the treatment options have been limited, but thanks to an international specialist in veterinary pharmaceuticals, Dechra, there is now one more FDA-approved drug, and this one comes in the form of a tablet. Laverdia®-CA1 is the brand name for…